Our patents of Talin Test have been registered in UK, France, Germany, and Italy.
We have presented our latest multi-center research about BiologicMate® for the efficacy of infliximab in 2016 EULAR Congress Meeting in London (June 8-11th, 2016). Details Here!
Kaytee Bio,Co.&Ltd. concluded the License Contracts on the distribution and R&D of our technology regarding BiologicMate® and Talin Test exclusively in the countries including U.S.A. with Japanese Organization for Medical Device Development, Inc (https://jomdd.com).